AU2022903624A0 - Treatment of central nervous system injury - Google Patents

Treatment of central nervous system injury

Info

Publication number
AU2022903624A0
AU2022903624A0 AU2022903624A AU2022903624A AU2022903624A0 AU 2022903624 A0 AU2022903624 A0 AU 2022903624A0 AU 2022903624 A AU2022903624 A AU 2022903624A AU 2022903624 A AU2022903624 A AU 2022903624A AU 2022903624 A0 AU2022903624 A0 AU 2022903624A0
Authority
AU
Australia
Prior art keywords
treatment
nervous system
central nervous
system injury
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2022903624A
Inventor
Andrew Clarkson
Sean Mackay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipoxagen Ltd
Original Assignee
Lipoxagen Ltd
Filing date
Publication date
Application filed by Lipoxagen Ltd filed Critical Lipoxagen Ltd
Publication of AU2022903624A0 publication Critical patent/AU2022903624A0/en
Assigned to Lipoxagen Limited reassignment Lipoxagen Limited Request for Assignment Assignors: CLARKSON, ANDREW, MACKAY, SEAN
Withdrawn legal-status Critical Current

Links

AU2022903624A 2022-11-30 Treatment of central nervous system injury Withdrawn AU2022903624A0 (en)

Publications (1)

Publication Number Publication Date
AU2022903624A0 true AU2022903624A0 (en) 2022-12-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP4010072A4 (en) Treatment of central nervous system disorders
EP4013403A4 (en) Methods of treating psychological and brain disorders
EP3805397A4 (en) Gene sequence construct used for treatment of central nervous system diseases
EP3908292A4 (en) Improved targeted t-cell therapy for treatment of multiple myeloma
EP4081238A4 (en) Treatment of mild traumatic brain injury
EP3911348A4 (en) Method of treating central nervous system disease
IL304628A (en) Treatment of skin disorders
AU2022903624A0 (en) Treatment of central nervous system injury
EP3955914A4 (en) Novel compounds and methods of use treating fructose-related disorders or diseases
AU2022242765A1 (en) Combined treatment of brain injury
EP4091621A4 (en) Method for treatment of nerve injury and related disease
EP3937947A4 (en) Treatment of inflammatory diseases of the central nervous system
GB202104590D0 (en) Treatment of the central nervous system
EP3934694A4 (en) Combination therapy for treatment of brain disorders
EP4069244A4 (en) Use of reboxetine to treat nervous system disorders
AU2022396530A1 (en) Methods of treating neurological disorders
GB202114129D0 (en) Treatment of traumatic brain injury
GB202107701D0 (en) Treatment of traumatic brain injury
GB202105648D0 (en) Treatment of traumatic brain injury
GB202006727D0 (en) Treatment of traumatic brain injury
GB202102247D0 (en) Treatment of brain injuries
EP4118066A4 (en) Treatment of disorders associated with oxidative stress and compounds for same
AU2021900740A0 (en) Combination Methods of Treatment
EP3965819A4 (en) Treatment of brain ischemia-reperfusion injury
AU2023902382A0 (en) Methods of treatment